Search For "pharmaceutical"
India's incentives for domestic API production could cut supply risk: Fitc
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 10 (ANI): The Indian government's recent incentives to boost domestic manufacturing of active pharmaceutical ingredients (APIs) and key starting materials (KSMs) can improve backward integration over the next few years and curtail supply-chain disruption ris
Read More
Alembic Pharmaceuticals raises Rs 750 crores via QIP, issue subscribed by
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] Aug 7 (ANI/PRNewswire): Alembic Pharmaceuticals, a Vadodara headquartered company, is a leading manufacturer of pharmaceuticals with three business verticals -International generics (approximately 58 per cent), Domestic branded formulations (approximately 31 per
Read More
Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce th
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India] Aug 6 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India.
Read More
Glenmark introduces higher strength of FabiFlu to reduce pill burden of Co
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 6 (ANI): Glenmark Pharmaceuticals will introduce a 400 mg version of oral anti-viral FabiFlu for the treatment of mild to moderate Covid-19 in India.
Read More
Lupin launches Favipiravir in India for COVID treatment at Rs 49 per table
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 5 (ANI): Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19.
Read More
Sun Pharma launches Favipiravir in India for Rs 35 per tablet
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 4 (ANI): Sun Pharmaceutical Industries said on Tuesday it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
Read More
Fire breaks out outside pharmaceutical company in Visakhapatnam
Updated : 5 years, 7 months ago IST
Visakhapatnam (Andhra Pradesh) [India], Aug 4 (ANI): A fire broke out outside a pharma company in Andhra Pradesh's Visakhapatnam district on Tuesday morning. No injuries have been reported in the incident.
Read More
Wockhardt announces Covid-19 vaccine partnership with UK government
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 3 (ANI): Pharmaceutical and biotechnology major Wockhardt said on Monday it has entered into an agreement with the UK Government to fill-finish Covid-19 vaccines.
Read More
Indian API companies to benefit as global customers try to reduce dependen
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 28 (ANI): India Ratings and Research (Ind-Ra) has said that Indian active pharmaceutical ingredient (API) companies will benefit from improving demand outlook in the United States.
Read More
Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More
Sun Pharma's arm Taro achieves global resolution of US DoJ anti-trust prob
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Sun Pharmaceutical Industries said on Friday its US-based subsidiary Taro Pharmaceutical Inc has resolved all cases in connection with multi-year investigations by the Department of Justice's (DoJ's) Anti-trust Division and Civil Division into the
Read More
Government plans to add 4-5 more sectors in production-linked incentive sc
Updated : 5 years, 8 months ago IST
New Delhi [India], July 23 (ANI): Apart from the mobile handset sector the Finance Ministry is looking at adding more sectors in production-linked incentive schemes, extending it to medical equipment and pharmaceuticals sectors, said Tarun Bajaj, Secretary, Department of Economic Affairs, Mi
Read More